Belgium· BE-AMP-SAM180975-00

Twinrix Paediatric

A kombinationen (hepatitis a + hepatitis b) product containing hepatitis b virus surface antigen (recombinant), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC20

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about hepatitis b virus surface antigen (recombinant)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search kombinationen (hepatitis a + hepatitis b) products by name

Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Hepatitis B virus surface antigen (recombinant)
Manufacturer: GlaxoSmithKline Biologicals
Country: Belgium (BE)
ATC code: J07BC20
ATC class: Kombinationen (Hepatitis A + Hepatitis B)
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Kombinationen (hepatitis a + hepatitis b) in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All kombinationen (hepatitis a + hepatitis b) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fa806355-b5d0-488f-a208-462e7f348f87
GET /v1/drugs/fa806355-b5d0-488f-a208-462e7f348f87?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Twinrix Paediatric",
  "name_fr": "Twinrix Enfant",
  "name_nl": "Twinrix Paediatric",
  "amp_code": "SAM180975-00",
  "strengths": [
    "0.0100",
    "360.0000",
    "360.0000",
    "0.0100"
  ],
  "pack_count": 3,
  "substances": [
    "Hepatitis B virus surface antigen (recombinant)",
    "Hepatitis A Virus Antigene (Hav Antigen) Vaccin",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "EU/1/97/029/005",
    "EU/1/97/029/003",
    "EU/1/97/029/004"
  ]
}

API reference MCP server Plans

See everything about kombinationen (hepatitis a + hepatitis b).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console